LS-T2 - Global, regional and national perspectives on the road map ahead for a global action plan on antimicrobial resistance


Organised by FIP AMR Commission in collaboration with GRIP and supported by Reckitt


Mrs Manjiri Gharat (AMR Commission Chair, India)
Prof. Sabiha Essack (FIP AMR Commission and GRIP member, South Africa)


Antimicrobial resistance (AMR) has always been a priority for FIP. Identified as a global health threat by the World Health Organization, awareness on AMR has recently gained momentum heightened by challenges posed by COVID-19, which has severely impacted progress made in previous years to combat AMR.
Following the launch of the FIP AMR Commission in September 2020, FIP has taken an inclusive approach to developing road maps on AMR across the six WHO regions. In this event, taking place at the Both FIP World Congress, FIP leadership and experts from the FIP AMR Commission (including GRIP) will present progress with AMR activities emerging from FIP member organisations. Member organisations will showcase AMR activities, initiatives and achievements mapped to the regional road maps on AMR developed in 2020 with support from FIP resources. The discussions and deliberations will culminate in the 2022 Commitment to Action to global, regional and national antimicrobial stewardship (AMS). These will then be showcased to FIP Member organisations more widely.




Introduction and setting the scene by the co-chairs



The Showcase session
AMR Country progress across WHO Regions: Presentations on behalf of national organisations and national perspectives, but also from the region, with examples from other nations, to provide both perspectives
Mr John Bell, University of Technology Sydney, Australia
Mr Khalid Eljaaly, King Abdulaziz University, Saudi Arabia
Dr Dalal Hammoudi Halat, Lebanese International University, Lebanon
Dr Elsa Lopez Pintor, Universidad Miguel Hernández de Elche, Spain
Dr Saed Nuh, Ministry of Health Development (MoHD), Somalia
Mrs Victoria Rutter,  The Commonwealth Pharmacists Association, UK
Dr Eduardo Savio, Centro Uruguayo de lmagenologfa Molecular, Uruguay
Dr Wirat Tongrod, Huachiew Chalermprakiet University, Thailand



Panel discussion

Prof. Catia Caneiras, Portuguese Pharmaceutical Society, Portugal
Prof. Debra Goff, Ohio State University Medical Center, USA

Mr Philip Howard/NHS England North-East & Yorkshire, UK
Prof. Mirfin Mpundu/React Africa, USA



The FIP AMR 2022 Commission Commitment
Panel discussion and Q&A managed by the co-chairs
Dr Catherine Duggan, Mrs Manjiri Gharat and Prof. Sabiha Essack

13:50 -14:00  

Mrs Manjiri Gharat, AMR Commission Chair


Learning Objectives

  1. To showcase examples from countries and FIP Member Organisations (MOs) across regions ­taking a variety of AMR activities.
  2. To present alignment to the AMR road maps from 2020 to demonstrate progress and gaps in the area.
  3. For FIP and the AMR Commission to sign a commitment to 2023-and beyond to national, regional and global AMR and AMS stewardship.
Back to top